Immuneering Q4 EPS $(0.52) Misses $(0.47) Estimate
Portfolio Pulse from Benzinga Newsdesk
Immuneering reported Q4 earnings with a loss of $0.52 per share, missing the consensus estimate of $0.47 by 10.64%. This represents a 4% increase in losses compared to the same period last year.
March 01, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Immuneering's Q4 earnings report showed a larger loss than expected, missing analyst estimates.
Missing earnings estimates, especially with an increased loss compared to the previous year, typically leads to negative investor sentiment in the short term. This could result in a decrease in stock price as the market reacts to the company's underperformance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100